ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 76, 2025
   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2016, Volume 67, Issue 6,





OANA VIOLA BADULESCU, MADALINA MOCANU, CRISTINA ELENA IANCU, MARIA MAGDALENA LEON CONSTNTIN, MAGDA BADESCU
Assessment of Hematological Toxicity in Case of Oral Administration of Metronidazole

Abstract:

Metronidazole is an antibacterial agent, which is part of nitroimidazole class. It is used, particularly, in the treatment of infections caused by anaerobic bacteria and protozoa. Metronidazole, orally administered, is recommended for the treatment of infections with anaerobic germs, specifically in the genitalia area (bacterial vaginitis) and in the abdominal area (Crohn’s disease, necrotising pancreatitis, gastritis) and it is a treatment prescribed in infection with Clostridium difficile (pseudomembranous colitis). Metronidazole is also frequently prescribed in the treatment of infection with Helicobacter pylori. Severe adverse effects induced by the intake of Metronidazole are known, such as: convulsive crises, encephalopathy, peripheral neuropathy, reversible neutropenia. The aim of this paper is to present the involvement of Metronidazole in the alteration of platelet function, pathology occurred in form of severe peripheral thrombocytopenia. We present the case of a 59-year old woman, diagnosed with gastritis with Helicobacter pylori, who, after having taken Metronidazole in order to fight the infection, presents severe hemorrhagic syndrome. Thrombocytopenia induced by Metronidazole is a rare adverse reaction, induced by immune mechanism. It is characterised by hemorrhagipar syndrome which occurs after primary haemostasis and clinically manifests at cutaneous-mucous level. Keywords: toxicity, Metronidazole, thrombocytopenia, anti-platelet antibodies, haemostasis

Issue: 2016, Volume 67, Issue 6
Pages:
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice